Avecho Biotechnology hosted an investor webinar and Q&A with CEO, Dr Paul Gavin, to discuss the Company’s investment proposition and rationale for its Entitlement Offer to provide funds for conducting a Phase III clinical trial in respect of the Company’s proprietary TPM enhanced CBD soft-gel capsule.